Kintara Therapeutics Inc Stock
Kintara Therapeutics Inc Stock price
Key metrics
| Market capitalization | $162.49m |
| Enterprise Value | $150.47m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 16.97 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-17.46m |
| Free Cash Flow (TTM) Free Cash Flow | $-13.81m |
| Cash position | $12.46m |
Is Kintara Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.
Kintara Therapeutics Inc Stock Analysis
Analyst Opinions
2 Analysts have issued a Kintara Therapeutics Inc forecast:
Analyst Opinions
2 Analysts have issued a Kintara Therapeutics Inc forecast:
Financial data from Kintara Therapeutics Inc
| Mar '25 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.08 -0.08 |
60%
60%
|
|
| EBITDA | -17 -17 |
43%
43%
|
EBIT (Operating Income) EBIT | -17 -17 |
43%
43%
|
| Net Profit | -19 -19 |
60%
60%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Kintara Therapeutics Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Kintara Therapeutics Inc Stock News
Company Profile
Kintara Therapeutics, Inc. is a clinical and biopharmaceutical company, which focuses on the development and commercialization of new cancer therapies. Its pipeline includes the VAL-083 and REM-001. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.
| Head office | United States |
| CEO | James Bianco |
| Employees | 19 |
| Founded | 2009 |
| Website | www.tuhurabio.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
